Search results
Author(s):
Vlado Perkovic
Added:
10 months ago
ADA 24 - In this succinct video, we are joined by Dr Vlado Perkovic (UNSW Sydney, Kensington, AU) to discuss a trial investigating the use of semaglutide in patients with type 2 diabetes and chronic kidney disease (NCT03819153).The FLOW trial enrolled 3533 participants with type 2 diabetes and chronic kidney disease, who were then randomized to recieve either semaglutide or placebo. The median…
View more
Author(s):
Jin-Ho Choi
,
Jung-Min Choi
,
Ki-Hong Choi
,
et al
Added:
7 months ago
Author(s):
Richard Pratley
Added:
8 months ago
EASD 24 - We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.Interview Questions:1. What is the reasoning behind the FLOW Trial?2. What was the patient population and study design?3. What are the key results?4. Were there any surprising or unexpected findings?5. What further…
View more
Author(s):
Harriette Van Spall
,
Added:
5 months ago
AHA Conference 2024 — Semaglutide shows increased benefits in CKD patients based on their cardiovascular status and risk profile.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Katherine Tuttle (University of Washington, US) to discuss the effects of semaglutide in patients with chronic kidney disease (CKD).The FLOW trial (NCT03819153) is designed to assess the effect of…
View more
Author(s):
Firas Zahr
Added:
1 year ago
THT 24 - We are joined by Dr Firas Zahr (OHSU Knight Cardiovascular Institute Cardiology Clinic, US) to discuss the findings from the ALT FLOW Early Feasibility study (NCT03523416).The ALT FLOW Early Feasibility study aims to assess the initial clinical safety, functionality and effectiveness of a transcatheter atrial shunt system created by Edwards. 75 patients with symptomatic heart failure…
View more
Author(s):
Shuo-wen Sun
,
Xing-jie Wang
,
Ruo-chen Yan
,
et al
Added:
4 weeks ago
Author(s):
Yimeng Zhang
,
Nimai Desai
,
Derek Connolly
Added:
2 months ago
ACC.24: The PROACT Trial
Author(s):
David Austin
Added:
1 year ago
Video
Author(s):
Antonio Mangieri
Added:
2 years ago
EuroPCR 23 – Dr Antonio Mangieri (Humanitas Research Hospital, IT) joins us to discuss the data from a study that compared BASILICA and Chimney stenting in high-risk TAVR patients.
The study found similar efficacy and outcomes between BASILICA and Chimney stenting at one year. BASILICA may reduce complications associated with ostial stenting and does not increase the risk of stroke with cerebral…
View more
Author(s):
Johanna McChord
,
Astrid Hubert
,
Udo Sechtem
,
et al
Added:
6 months ago